Recombinant Trypanosoma cruzi antigens and Chagas' disease diagnosis: analysis of a workshop

47Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

A workshop organized by the Ibero-American Project of Biotechnology evaluated the diagnostic potential of several cloned Trypanosoma cruzi recombinant antigens for Chagas' disease serodiagnosis. A set of recombinants, Antigen 2, Antigen 13, SAPA, H49, A13, JL5, JL7, JL8, JL9, and RA1 provided by three different South American laboratories were probed with a panel of 236 South American serum samples. Antigens JL7, H49, Antigen 2, and A13 scored as the best diagnostic recombinant reagents. The results suggested that the main advantage of using cloned peptides for chronic Chagas' disease diagnosis resided in their highly specific immunoreactive properties. © 1991.

Cite

CITATION STYLE

APA

Levin, M. J., Franco da Silveira, J., Frasch, A. C. C., Camargo, M. E., Lafon, S., Degrave, W. M., & Rangel-Aldao, R. (1991). Recombinant Trypanosoma cruzi antigens and Chagas’ disease diagnosis: analysis of a workshop. FEMS Microbiology Letters. https://doi.org/10.1111/j.1574-6968.1991.tb04965.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free